It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Human cytomegalovirus (HCMV) is a widespread pathogen that in immunocompromised hosts can cause life-threatening disease. Studying HCMV-exposed monocyte-derived dendritic cells by single-cell RNA sequencing, we observe that most cells are entered by the virus, whereas less than 30% of them initiate viral gene expression. Increased viral gene expression is associated with activation of the stimulator of interferon genes (STING) that usually induces anti-viral interferon responses, and with the induction of several pro- (RHOB, HSP1A1, DNAJB1) and anti-viral (RNF213, TNFSF10, IFI16) genes. Upon progression of infection, interferon-beta but not interferon-lambda transcription is inhibited. Similarly, interferon-stimulated gene expression is initially induced and then shut off, thus further promoting productive infection. Monocyte-derived dendritic cells are composed of 3 subsets, with one being especially susceptible to HCMV. In conclusion, HCMV permissiveness of monocyte-derived dendritic cells depends on complex interactions between virus sensing, regulation of the interferon response, and viral gene expression.
Human cytomegalovirus (HCMV) is a ubiquitous pathogen associated with morbidity and mortality in the immunocompromised or immunonaive context. Here the authors show that HCMV exploits STING signalling and subverts the interferon response to support infection of monocyte derive dendritic cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details














1 a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877)
2 Helmholtz-Centre for Infection Research (HZI), Helmholtz Institute for RNA-based Infection Research (HIRI), Würzburg, Germany (GRID:grid.498164.6)
3 Centre for Individualised Infection Medicine (CiiM) & TWINCORE, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Department of Computational Biology for Individualised Medicine, Hannover, Germany (GRID:grid.512472.7)
4 Centre for Individualised Infection Medicine (CiiM) & TWINCORE, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Department of Computational Biology for Individualised Medicine, Hannover, Germany (GRID:grid.512472.7); Radboud University Medical Center, Department of Internal Medicine and Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands (GRID:grid.461760.2)
5 Helmholtz Centre for Infection Research, Institute for Immune Aging and Chronic Infection, Braunschweig, Germany (GRID:grid.7490.a) (ISNI:0000 0001 2238 295X)
6 Hannover Medical School, Institute for Transfusion Medicine and Transplant Engineering, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877)
7 Hannover Medical School, Institute of Virology, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877)
8 University of Würzburg, Institute for Virology and Immunobiology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
9 Helmholtz-Centre for Infection Research (HZI), Helmholtz Institute for RNA-based Infection Research (HIRI), Würzburg, Germany (GRID:grid.498164.6); Institute of Molecular Infection Biology (IMIB), University of Würzburg, Faculty of Medicine, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
10 University of Würzburg, Institute for Virology and Immunobiology, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); University of Regensburg, Faculty for Informatics and Data Science, Regensburg, Germany (GRID:grid.7727.5) (ISNI:0000 0001 2190 5763)
11 a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877); Hannover Medical School, Cluster of Excellence - Resolving Infection Susceptibility (RESIST, EXC 2155), Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877)